Agios
Agios Pharmaceuticals is a public American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias.
- VP and Head of Clinical Development 
- Senior Medical Director Rare Genetic Disease 
- Head of Rare Disease Clinical Development 
- VP of Global Clinical Operations 
- Medical Director / Senior Medical Director Hematology 
- Director Clinical Science 
 
                        